BioNTech SE (BNTX) Gross Margin (2018 - 2026)
BioNTech SE (BNTX) recorded Gross Margin of 91.99% in Q3 2026, up 1.75 percentage points from 90.24% a year earlier and up 83.84 percentage points from the prior quarter.
Powered by 
Analysis
BioNTech SE (BNTX) Gross Margin (2018 - 2026) Analysis & Trends
On a TTM basis, BioNTech SE's Gross Margin came in at 74.89% as of Sep 30, 2026, down 7.90 percentage points year-over-year; for FY2025, it came in at 77.64%, down 2.69 percentage points from FY2024.
- Annual Gross Margin has a five-year change of -10.07 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 80.32% in FY2024 (-3.97 pp), 84.29% in FY2023 (+1.60 pp), 82.70% in FY2022 (-1.96 pp) and 84.66% in FY2021 (-3.05 pp).
- The Q3 2026 figure is the highest quarterly Gross Margin since Q1 2023.
- On a year-over-year basis, Gross Margin rose in three of the last eight quarters, with an average year-over-year change of -11.58 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 50.67 percentage points in Q2 2024, against a drop of 73.22 percentage points in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 8.14% (Q2 2026), 39.54% (Q1 2026) and 63.27% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | BioNTech SE | 22.05 Bn | -37.46 Bn | 1.36 Bn | 91.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 91.99% |
| Jun 30, 2026 | 8.14% |
| Mar 31, 2026 | 39.54% |
| Dec 31, 2025 | 63.27% |
| Sep 30, 2025 | 90.24% |
| Jun 30, 2025 | 70.71% |
| Mar 31, 2025 | 54.16% |
| Dec 31, 2024 | 79.54% |
| Sep 30, 2024 | 85.63% |
| Jun 30, 2024 | 53.54% |
| Mar 31, 2024 | 68.50% |
| Dec 31, 2023 | 87.89% |
| Sep 30, 2023 | 81.93% |
| Jun 30, 2023 | 2.86% |
| Mar 31, 2023 | 92.48% |
| Dec 31, 2022 | 95.71% |
| Sep 30, 2022 | 78.25% |
| Jun 30, 2022 | 76.08% |
| Mar 31, 2022 | 79.70% |
| Dec 31, 2021 | 89.46% |
API Access
BioNTech SE Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();